This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Nucleic acid substance: Mipomersen sodium — antisense oligonucleotide targeting APOB-100
{
"resourceType" : "SubstanceDefinition",
"id" : "mipomersen",
"identifier" : [{
"system" : "http://example.europa.eu/fhir/SMSId",
"value" : "MIPO78654S"
}],
"status" : {
"coding" : [{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active"
}]
},
"classification" : [{
"coding" : [{
"system" : "http://example.europa.eu/fhir/SubstanceType",
"code" : "nucleic-acid",
"display" : "Nucleic Acid"
}]
}],
"domain" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Domain",
"code" : "human",
"display" : "Human use"
}]
},
"description" : "Mipomersen sodium — a synthetic second-generation 2'-methoxyethyl antisense oligonucleotide that inhibits the molecular target apolipoprotein B-100 (APOB-100). 20-mer phosphorothioate-linked sequence with 2'-MOE wing chemistry.",
"code" : [{
"code" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Substance",
"code" : "MIPO78654S"
}]
}
}],
"name" : [{
"name" : "Mipomersen Sodium",
"preferred" : true,
"language" : [{
"coding" : [{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "English"
}]
}],
"official" : [{
"authority" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-name-authority",
"code" : "INN",
"display" : "INN"
}]
},
"status" : {
"coding" : [{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}]
}
}]
}],
"nucleicAcid" : {
"sequenceType" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-sequence-type",
"code" : "complete",
"display" : "Complete"
}]
},
"numberOfSubunits" : 1,
"oligoNucleotideType" : {
"coding" : [{
"system" : "http://hl7.org/fhir/oligo-nucleotide-type",
"code" : "antisense",
"display" : "Antisense oligonucleotide"
}]
},
"subunit" : [{
"subunit" : 1,
"sequence" : "GCCUCAGTCTGCTTCGCACC",
"length" : 20,
"fivePrime" : {
"coding" : [{
"system" : "http://hl7.org/fhir/nucleotide-terminus",
"code" : "G",
"display" : "Guanosine"
}]
},
"threePrime" : {
"coding" : [{
"system" : "http://hl7.org/fhir/nucleotide-terminus",
"code" : "C",
"display" : "Cytidine"
}]
},
"linkage" : [{
"substance" : {
"concept" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/LinkageSubstance",
"code" : "phosphorothioate",
"display" : "Phosphorothioate linkage"
}]
}
},
"residueSite" : "1-19"
}],
"sugar" : [{
"substance" : {
"concept" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/SugarSubstance",
"code" : "2-MOE",
"display" : "2'-O-(2-methoxyethyl) ribose"
}]
}
},
"residueSite" : "1-5,16-20"
},
{
"substance" : {
"concept" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/SugarSubstance",
"code" : "deoxyribose",
"display" : "2'-deoxyribose"
}]
}
},
"residueSite" : "6-15"
}]
}],
"gene" : [{
"sequenceOrigin" : {
"coding" : [{
"system" : "http://hl7.org/fhir/gene-sequence-origin",
"code" : "human",
"display" : "Human"
}]
},
"gene" : {
"concept" : {
"coding" : [{
"system" : "http://www.genenames.org",
"code" : "APOB",
"display" : "apolipoprotein B"
}]
}
}
}]
},
"relationship" : [{
"substanceDefinitionCodeableConcept" : {
"coding" : [{
"system" : "https://www.uniprot.org",
"code" : "P04114",
"display" : "apolipoprotein B-100"
}]
},
"type" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-relationship-type",
"code" : "TherapeuticTarget",
"display" : "Therapeutic target"
}]
},
"interaction" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-interaction-type",
"code" : "inhibition",
"display" : "Inhibition"
}]
}
}]
}
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.